RxSight Inc (RXST)

34.22 -0.83 (-2.37%) USD  |  NASDAQ  |  Dec 27, 16:00
34.25 +0.03 (+0.09%) Pre-Market: 20:00
More

RxSight Research and Development Expense (Quarterly): 8.838M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
PROCEPT BioRobotics Corp 16.65M
Perspective Therapeutics Inc 12.03M
Retractable Technologies Inc 0.1747M
Xtant Medical Holdings Inc 0.701M
Catheter Precision Inc 0.063M